Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential
David E. Shaw is one billionaire investor whose record speaks for itself on Wall Street. Having founded D.E. Shaw & Co., L.P.
Posts Tagged ‘NASDAQ:PTCT’
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2025 Earnings Call Transcript
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2025 Earnings Call Transcript May 6, 2025PTC Therapeutics, Inc. beats earnings expectations.
11 Best Gene Therapy Stocks to Buy According to Analysts
Gene therapy is a medical approach that entails changing or modifying genes to treat or prevent disease.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2024 Earnings Call Transcript
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2024 Earnings Call Transcript February 27, 2025PTC Therapeutics, Inc. beats earnings expectations.
Why PTC Therapeutics (PTCT) Stock Is Rallying Today
PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald' hiked its price target on the drug maker's shares to $113 from $76.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2024 Earnings Call Transcript
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2024 Earnings Call Transcript November 7, 2024PTC Therapeutics, Inc. beats earnings expectations.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to PTC Second Quarter 2024 Financial Results Conference Call.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript
PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.2, expectations were $-1.31. PTC Therapeutics, Inc.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2023 Earnings Call Transcript
PTC Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.24 EPS, expectations were $0.29.
Analysts on Wall Street Lower Ratings for These 5 Stocks
In this article, we discuss the 5 stocks receiving downgrades from analysts.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by and welcome to the PTC Therapeutics Third Quarter 2023 Financial Results Conference Call.
PTC Therapeutics (PTCT) Lost 16% in Q2
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter investor letter.
Analysts on Wall Street Lower Ratings for These 5 Stocks
In this article, we discuss the 5 stocks receiving downgrades from analysts.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by and welcome to the PTC Second Quarter 2023 Financial Results Conference Call.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by and welcome to the PTC First Quarter 2023 Financial Results Call. All participants are in a listen-only mode.
12 High Growth Healthcare Stocks to Buy
The healthcare sector proved its mettle in 2022.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2022 Earnings Call Transcript
Operator: Good day, and welcome to the PTC Therapeutics Fourth Quarter 2022 Corporate Update and Financial Results Call.
13 Best Genomics Stocks To Buy Now
Before talking about the best genomics stocks, it is important to understand what the term actually means.
5 Best Pharmaceutical Stocks to Buy According to Steven Boyd’s Armistice Capital
In this article, we will take a look at some important pharma stock picks of Steven Boyd's Armistice Capital.
PTC Therapeutics, Inc. (PTCT): Hedge Fund Sentiment Unchanged
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Where Do Hedge Funds Stand On PTC Therapeutics, Inc. (PTCT)?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Do Hedge Funds Love PTC Therapeutics, Inc. (PTCT)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is PTCT Stock A Buy or Sell?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change...
Hedge Fund and Insider Trading News: Dan Niles, Citadel LLC, Alden Global Capital, Alexco Resource Corp. (AXU), Facebook Inc (FB), Canadian National Railway (CNI), and More
Tribune Publishing Co. said it appointed a special committee to review a buyout bid proposed by its largest shareholder, New York hedge fund Alden Global Capital LLC.
Top 5 Healthcare Stocks for the Future
Below we present the list of Top 5 Healthcare Stocks for the Future. For the first half of the list and an introduction to Dr.
Hedge Fund and Insider Trading News: Jeff Smith, Dan Loeb, Warren Buffett, Toscafund Asset Management, Workday Inc (WDAY), Dicks Sporting Goods Inc (DKS), and More
Activist investor Jeff Smith pitched two new stocks at a conference on Thursday, sending shares jumping in early trading.
Hedge Funds Are Dipping Their Toes Back Into PTC Therapeutics, Inc. (PTCT)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Did Hedge Funds Make The Right Call On PTC Therapeutics, Inc. (PTCT) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Are Selling PTC Therapeutics, Inc. (PTCT)
In this article we will take a look at whether hedge funds think PTC Therapeutics, Inc. (NASDAQ:PTCT) is a good investment right now.
Do Hedge Funds Love PTC Therapeutics, Inc. (PTCT)?
We hate to say this but, we told you so.
Hedge Fund Favorites vs. PTC Therapeutics, Inc. (PTCT) In 2019
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019.
Hedge Funds Have Never Been This Bullish On PTC Therapeutics, Inc. (PTCT)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Is PTC Therapeutics, Inc. (PTCT) A Good Stock To Buy ?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Hedge Funds Have Never Been This Bullish On PTC Therapeutics, Inc. (PTCT)
World-class money managers like Ken Griffin and Barry Rosenstein only invest their wealthy clients' money after undertaking a rigorous examination of any potential stock.
Here is What Hedge Funds Think About PTC Therapeutics, Inc. (PTCT)
"Market conditions are changing.
Hedge Funds Are Buying PTC Therapeutics, Inc. (PTCT)
How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly traded companies.
Amazon, Pandora, PTC Therapeutics, and More: Why These Stocks Are Trending
Although November 6 is very important to the stock market because it's election day in the United States, traders are also paying attention to several equities that are trending...
13G Filing: Great Point Partners and PTC Therapeutics Inc. (PTCT)
You can access the original SEC filing by clicking here.
Biotech Movers On Friday: Neurotrope Inc (NTRP) And PTC Therapeutics, Inc. (PTCT)
Here’s a look at some of the week’s biggest movers in biotech, what’s moving them, and where we expect things to go early next week and beyond.
Here’s What Happened To Karyopharm Therapeutics Inc (KPTI) And PTC Therapeutics, Inc. (PTCT)
The end of the week is upon us, and it’s been a bit of a wild ride in the biotech space.
Is PTC Therapeutics, Inc. (PTCT) a Good Stock to Buy?
There are several ways to beat the market, and investing in small cap stocks has historically been one of them.
Why Tesla, PTC Therapeutics, Freeport-McMoRan, and Two More Are in the Spotlight
Although the broader indexes are relatively quiet, crude futures are down more than 2% in afternoon trading as some traders continue to doubt that OPEC will be able to get its...
Trending Stocks: PTC Therapeutics, GrubHub, Best Buy Co, and More
It's another quiet day on Wall Street as the three major indexes are just moderately in the red. The Dow is down by 22 points, while the NASDAQ and S&P 500 are off 0.15% and...
Here’s Why These Five Stocks Are in the Spotlight Today
In this article, we will examine the reasons why PTC Therapeutics, Inc.
Ups And Downs In Biotech This Week: PTC Therapeutics, Inc. (PTCT), Puma Biotechnology Inc (PBYI) and Nektar Therapeutics (NKTR)
It’s been another busy start to the week in biotech, with a number of companies moving double digit percentage points on various fundamental releases.
PTC Therapeutics, Opus Bank, Pearson, and More: What Is Going on With These Falling Stocks?
Although the broader markets are just down by a fraction of a percent, shares of five companies, PTC Therapeutics, Inc. (NASDAQ:PTCT), W&T Offshore, Inc.
Ptc Therapeutics Inc. (PTCT): Camber Capital Management Adds 500,000 Shares to Its Position
Stephen DuBois' Camber Capital Management recently filed a Form 13G with the SEC, in which it reported raising its stake in Ptc Therapeutics Inc.
NASH Hype Has These 2 Stocks Soaring, Plus the Latest On MGT Capital, PTC Therapeutics, and Cloud Peak Energy
There is little fear on the Street today, as all three major indexes are moderately higher.
Sarepta Therapeutics Inc (SRPT), PTC Therapeutics, Inc. (PTCT) and More: Here’s Why These Stocks Are on Investors’ Radars Today
Wall Street is in bull mode today as all three major indexes are in the green, with the Dow rising 90 points, the S&P 500 increasing 0.5% and the NASDAQ inching up 0.4%.
Hedge Funds Wisely Fled These Tanking Stocks
The importance of hedge fund sentiment is not only reflected by the long positions that these firms take in high flying companies, but also how quickly are they able to back out...
